1. Home
  2. CPIX vs VERU Comparison

CPIX vs VERU Comparison

Compare CPIX & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • VERU
  • Stock Information
  • Founded
  • CPIX 1999
  • VERU 1971
  • Country
  • CPIX United States
  • VERU United States
  • Employees
  • CPIX N/A
  • VERU N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPIX Health Care
  • VERU Health Care
  • Exchange
  • CPIX Nasdaq
  • VERU Nasdaq
  • Market Cap
  • CPIX 68.7M
  • VERU 76.9M
  • IPO Year
  • CPIX 2009
  • VERU 1990
  • Fundamental
  • Price
  • CPIX $5.28
  • VERU $0.53
  • Analyst Decision
  • CPIX
  • VERU Strong Buy
  • Analyst Count
  • CPIX 0
  • VERU 2
  • Target Price
  • CPIX N/A
  • VERU $4.00
  • AVG Volume (30 Days)
  • CPIX 38.4K
  • VERU 3.3M
  • Earning Date
  • CPIX 05-06-2025
  • VERU 05-08-2025
  • Dividend Yield
  • CPIX N/A
  • VERU N/A
  • EPS Growth
  • CPIX N/A
  • VERU N/A
  • EPS
  • CPIX N/A
  • VERU N/A
  • Revenue
  • CPIX $41,083,299.00
  • VERU $16,886,419.00
  • Revenue This Year
  • CPIX N/A
  • VERU N/A
  • Revenue Next Year
  • CPIX N/A
  • VERU N/A
  • P/E Ratio
  • CPIX N/A
  • VERU N/A
  • Revenue Growth
  • CPIX 5.82
  • VERU 134.43
  • 52 Week Low
  • CPIX $1.04
  • VERU $0.45
  • 52 Week High
  • CPIX $7.25
  • VERU $1.42
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 53.74
  • VERU 53.36
  • Support Level
  • CPIX $4.81
  • VERU $0.48
  • Resistance Level
  • CPIX $6.21
  • VERU $0.67
  • Average True Range (ATR)
  • CPIX 0.50
  • VERU 0.04
  • MACD
  • CPIX -0.00
  • VERU 0.00
  • Stochastic Oscillator
  • CPIX 38.00
  • VERU 25.37

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: